Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclic Neutropenia”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Post-approval studies (Phase 4)Study completedNCT04009941
What this trial is testing

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Peking University 104
Not applicableStudy completedNCT02921191
What this trial is testing

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Who this might be right for
Breast CancerLung Cancer
Biologics & Biosimilars Collective Intelligence Consortium 57,725
Not applicableUnknownNCT02806557
What this trial is testing

Profiling Neutrophil Counts in Patients on Chemotherapy

Who this might be right for
NeoplasmsNeutropeniaFebrile Neutropenia
University of Leeds 200
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT00035620
What this trial is testing

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Who this might be right for
SarcomaNeutropenia
Amgen 44
Testing effectiveness (Phase 2)Study completedNCT01923545
What this trial is testing

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Who this might be right for
Chemotherapy Induced Neutropenia
Dong-A ST Co., Ltd. 61
Testing effectiveness (Phase 2)Study completedNCT01648322
What this trial is testing

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 232
Testing effectiveness (Phase 2)Ended earlyNCT03559387
What this trial is testing

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
Prolong Pharmaceuticals 9
Post-approval studies (Phase 4)Study completedNCT00125723
What this trial is testing

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

Who this might be right for
Neutropenia
Amgen 2,252
Testing effectiveness (Phase 2)Study completedNCT02005458
What this trial is testing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
Xiamen Amoytop Biotech Co., Ltd. 80
Large-scale testing (Phase 3)Study completedNCT00536081
What this trial is testing

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Who this might be right for
Breast CancerChemotherapyFebrile Neutropenia
Academisch Ziekenhuis Maastricht 172
Large-scale testing (Phase 3)Study completedNCT04466137
What this trial is testing

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Who this might be right for
Non-Myeloid Malignancy
Xiamen Amoytop Biotech Co., Ltd. 398
Very early researchLooking for participantsNCT07066085
What this trial is testing

Serial Blood Count Study

Who this might be right for
Cyclic NeutropeniaCongenital NeutropeniaNeutropenia
University of Washington 20
Early research (Phase 1)Ended earlyNCT05622058
What this trial is testing

ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Who this might be right for
Prevention of Chemotherapy-induced Myelosuppression
Aileron Therapeutics, Inc. 6
Large-scale testing (Phase 3)Study completedNCT01674855
What this trial is testing

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Who this might be right for
Chemotherapy Induced Neutropenia
Dong-A ST Co., Ltd. 74